Foghorn Therapeutics Inc.
FHTX | NASDAQ
$4.15
+$0.01 (+0.24%)
At close: Sep 21, 2026, 4:00 PM ET
$4.25
+$0.10 (+2.41%)
After-hours:
Sep 21, 2026, 7:41 PM ET
Market Data
Market Cap $243.66M
Enterprise Value $119.18M
Beta 2.86
Average Volume 275.58K
Shares Outstanding (Diluted) 70.63M
Shares Change YoY 12.15%
Institutional Ownership 63.91%
Exchange NASDAQ
ISIN US3441741077
Price Performance
Price Change 1M -42.5%
Price Change 3M 0.2%
Price Change 6M -15.8%
Price Change YTD -20.0%
Price Change 1Y -16.7%
Price Change 3Y -31.4%
Price Change 5Y -70.8%
1M CAGR (ann.) -31.6%
1Y CAGR (ann.) -19.3%
5Y CAGR (ann.) -19.9%
All-Time CAGR -22.1%
Valuation
PE Ratio -4.19
Forward PE N/A
PEG Ratio -0.23
Forward PEG -0.35
PS Ratio 6.63
Forward PS 7.40
PB Ratio -3.01
P/FCF Ratio -2.85
P/Adj. FCF Ratio -2.63
P/OCF Ratio -3.43
EV/Sales 3.24
EV/EBIT -1.85
EV/EBITDA -1.91
EV/FCF -1.40
Earnings Yield -23.9%
FCF Yield -35.0%
Adj. FCF Yield -38.0%
Financial Health
Net Cash $124.48M
Total Debt $43.1M
Cash & Short-Term Investments $167.58M
Total Assets $203.39M
Current Ratio 3.36
Quick Ratio 3.36
Debt / Equity Ratio -0.53
Debt / EBITDA -0.69
Debt / FCF -0.51
OCF / Debt -1.98
Interest Coverage 0.00
Altman Z-Score -4.19
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 42.7%
Operating Profit Margin -186.4%
EBITDA Margin -170.1%
Net Profit Margin -175.8%
FCF Margin -232.3%
Adj. FCF Margin -251.8%
SBC / Revenue 19.5%
SBC Impact (per share) -8.4%
Returns
Return on Assets -31.8%
Return on Equity 72.6%
Return on Invested Capital -44.0%
Return on Capital Employed -44.8%
Return on Tangible Assets -31.8%
Historical Growth (CAGR)
Revenue CAGR 3Y 19.1%
Revenue CAGR 5Y 105.8%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 34.8%
EPS CAGR 5Y -64.8%
EPS CAGR 10Y N/A
FCF CAGR 3Y 12.8%
FCF CAGR 5Y -183.3%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 9
EPS Growth Next 3Y 12.1%
Revenue Growth Next 3Y 0.8%
Earnings Date Nov 3, 2026
EPS Estimate (next Q) -$0.22
EPS Growth Est (next Q) -12.0%
Revenue Est (next Q) $7.09M
Revenue Growth Est (next Q) -13.0%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $13.86
Price Target Upside 234.0%
Cash Flow
Operating Cash Flow $-85.3M
Free Cash Flow $-85.35M
Adj. Free Cash Flow $-92.52M
FCF Per Share -$1.21
OCF Per Share -$1.21
OCF/S Ratio -232.2%
Income Statement
Revenue $36.74M
Gross Profit $15.7M
Operating Income $-68.48M
EBITDA $-62.49M
Net Income $-64.58M
EPS (Diluted) -$0.99
Revenue / Employee $346.59K
Profit / Employee $-609.24K
Employees 106
Add to Watchlist
Select watchlists to add or remove FHTX